Fundamental Analysis of Emergent Biosolutions Inc - Growth / Value Index
EBS - Valuation Highlights
Valuation Analysis
Undervalued - Price to Intrinsic Value of 0.0404
Price to Book Ratio is 0.268 indicating that it is undervalued.
Tsr Value Index - Very Poor Score of 18.75
Valuation Key Ratios
| Ratio | TTM | Latest FY | Yoy Change | MRQ |
|---|---|---|---|---|
| Price to Earning | -0.500 | -1.24 | 6.88 % | |
| Price to Book | 0.292 | 0.201 | -6.88 % | 0.436 |
| Price to Sales | 0.240 | 0.248 | -6.88 % | |
| Enterprise Value to EBITDA Multiple | -4.26 | -30.21 | -16.94 % |
EBS - Profitability Highlights
Profitability Analysis
Steady Growth in EPS for last four quarters
Tsr Profitability Index - Very Poor Score of 11.88
Very Low Dividend Yield of 0.790 %
Negative Net profit for last two years
Profitability Key Ratios
| Ratio | TTM | Latest FY | Yoy Change | MRQ |
|---|---|---|---|---|
| Return On Equity | -58.46 | -16.18 | 0 % | 1.36 |
| Return On Asset | -23.81 | -7.07 | 0 % | 0.499 |
| Net Profit Margin | -47.89 | -19.97 | 0 % | 3.00 |
| Operating Profit Margin | -45.26 | -14.81 | 3.88 % | 13.25 |
| EBITDA Margin | -20.84 | -3.07 | 16.30 % | 22.84 |
Highlights
| Market Cap | 290829 K |
| Enterprise Value | 1052.03 M |
| Price/Book TTM | 0.292 |
| Outstanding Share | 52401.80 K |
| Float/ Outstanding Share | 98.65% |
| Dividend Yield | 0.790 % |
Share Holding
Guru Numbers
| Price/Graham No | 0 |
| Peter Lynch Ratio | 0 |
| Piotroski F Score | 3.00 |
| Altman Z Score | 0.602 |
| Sloan Ratio | -0.060 |
| Peter Lynch Fair Value | 0 |
EBS - Growth Highlights
Growth Analysis
Steady increase in Total Assets for last 3 Years
Tsr Growth Index - Poor Score of 22.71
Annual sales in last 3 years is trending down
Operating Cash Flow decreasing for last 3 year
Growth Key Fields
| Field | TTM | YoY Growth | QoQ Growth |
|---|---|---|---|
| Revenue | 1185.40 M | 0 % | 8.60 % |
| Gross Profit | 512000 K | 38.69 % | 83.66 % |
| EBITDA | -247000.00 K | 16.30 % | 686.32 % |
| Net Profit | -567700.00 K | 0 % | 118.18 % |
| EPS | -11.09 | 7.39 % | NA |
EBS - Stability Highlights
Stability Analysis
Tsr Stability Index - Poor Score of 20.31
Altman Z Score of 0.594 suggest high risk
Company is unable to generate enough free cash to support the business.
Interest Coverage of -4.76
Stability Key Ratios
| Ratio | Latest FY | Yoy Change | MRQ |
|---|---|---|---|
| Debt to Equity Ratio | 1.02 | -0.142 % | 1.37 |
| Cash Ratio | 0.522 | 0 % | |
| Quick Ratio | 0.698 | 0 % | 0.554 |
| Shareholders Equity | 43.67 | 0 % | |
| Debt to EBITDA | -40.81 | -19.31 % |
Historical Valuation Ratios of Emergent Biosolutions Inc
Historical Valuation Ratios
Loading ...
Historical Profitability Ratios of Emergent Biosolutions Inc
Historical Profitability Ratios
Loading ...
Historical Efficiency Ratios of Emergent Biosolutions Inc
Historical Efficiency Ratios
Loading ...
Historical Solvency Ratios of Emergent Biosolutions Inc
Historical Solvency Ratios
Loading ...
Note : All Data Generated at the End of Trading Hours (EOD Data)